Arch Chemicals Hires Dr. Alex Valcke as Vice President, Innovation
29 Ottobre 2009 - 1:12PM
Business Wire
Dr. Alex Valcke will be joining Arch Chemicals (NYSE: ARJ) as
Vice President, Innovation, effective November 1, 2009 and
reporting to Arch Chairman, President and CEO Michael E. Campbell.
In this capacity, he will work closely with Arch’s senior
management team and its businesses to ensure that Arch is pursuing
and investing in the best R&D efforts that support the
Company’s business strategies. In addition, he will identify and
drive cross-business as well as external technology
opportunities.
Dr. Valcke comes to Arch after a 25-year career at Janssen
Pharmaceutica NV (part of the Johnson & Johnson family of
companies), where he most recently held the position of General
Manager, Preservation and Material Protection Division. During his
career at Janssen, he gained valuable experience as a business
leader, managed key divestments and acquisitions for the division,
and led a successful effort to significantly expand the company’s
new product portfolio. He is also an inventor and co-inventor for
several patents in the field of material protection biocides and
has extensive experience in technology licensing.
“Alex Valcke brings to Arch the creative drive, the technology
depth and the business breadth that will help lead us to the next
level of innovation and growth,” said Mr. Campbell. “His extensive
background and experience in microbiology, new product development
and wood technology is perfectly suited for Arch’s core biocides
portfolio.”
Dr. Valcke graduated from the University of Ghent in Belgium
with a specialty focus in microbiology, forestry engineering and
wood technology. He earned his Ph.D. in Bio-engineering sciences
from the University of Ghent and obtained an additional Management
Education from the Vlerick Leuven Gent Management School. Among his
many professional associations and accomplishments, he held
senior-level positions at the International Research Group on Wood
Preservation, where he became the first person from industry to be
elected president.
Located in Antwerp, Belgium, Dr. Valcke will spend a substantial
part of his time in the United States and at Arch technology
centers and other locations around the globe.
Headquartered in Norwalk, Connecticut (USA), Arch Chemicals,
Inc. is a global biocides company with approximately $1.5 billion
in annual sales. Arch and its subsidiaries provide innovative,
chemistry-based solutions to control the growth of harmful
microbes. The Company’s concentration is in water treatment, hair
and skin care products, treated wood, preservation and protection
applications such as for paints and building products, and health
and hygiene applications. Arch Chemicals operates in two segments:
Treatment Products and Performance Products. Together with its
subsidiaries, Arch has approximately 3,000 employees worldwide and
manufacturing and customer-support facilities in North and South
America, Europe, Asia, Australia and Africa. For more information,
visit www.archchemicals.com.
Grafico Azioni Arch Chemicals (NYSE:ARJ)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Arch Chemicals (NYSE:ARJ)
Storico
Da Lug 2023 a Lug 2024